Kim Janda Sorrento Therapeutics, Inc. (SRNE) insider trading activity

Kim Janda is Director of Sorrento Therapeutics, Inc.. Currently has a direct ownership of 3,000 shares of SRNE, which is worth approximately $990. The most recent transaction as insider was on Dec 27, 2021, when has been sold 3,000 shares (Common Stock) at a price of $5.88 per share, resulting in proceeds of $17,640. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3K

0% 3M change

0% 12M change

Total Value Held $990

Kim Janda Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 27 2021	SELL Open market or private sale	$17,640 $5.88 p/Share	3,000 Reduced 50.0%	3,000 Common Stock
Dec 27 2021	BUY Exercise of conversion of derivative security	$12,000 $4.0 p/Share	3,000 Added 33.33%	6,000 Common Stock
Sep 27 2021	SELL Open market or private sale	$339,703 $8.02 p/Share	42,357 Reduced 93.39%	3,000 Common Stock
Sep 27 2021	BUY Exercise of conversion of derivative security	$113,940 $2.69 p/Share	42,357 Added 48.29%	45,357 Common Stock
Sep 13 2021	SELL Open market or private sale	$64,320 $8.04 p/Share	8,000 Reduced 72.73%	3,000 Common Stock
Sep 13 2021	BUY Exercise of conversion of derivative security	$28,000 $3.5 p/Share	8,000 Added 42.11%	11,000 Common Stock
Apr 12 2021	SELL Open market or private sale	$13,243 $6.97 p/Share	1,900 Reduced 38.78%	3,000 Common Stock
Apr 12 2021	BUY Exercise of conversion of derivative security	$6,650 $3.5 p/Share	1,900 Added 27.94%	4,900 Common Stock

Kim Janda

Director

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRNE shares.

Notify only if

Value

Insider Trading

Get notified when an Sorrento Therapeutics, Inc. insider buys or sells SRNE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Sorrento Therapeutics, Inc.

Track Activities on SRNE

Account